Inventor · disambiguated record
Raphael Schiffmann
Also filed as: SCHIFFMANN RAPHAEL
6 granted patents·4 pending applications·107 citations·filing 2010–2018
82Inventor score
Files withBAYLOR RES INST3SCHIFFMANN RAPHAEL3NATIONAL INSTITUTE OF HEALTH AND MEDICAL RES2MENG XINGLI1NAT INST OF HEALTH AND MEDICAL RES1
Top patents by PatentIndex Score
10 records- 0194US9750732B2Urinary triaosylceramide (Gb3) as a marker of cardiac diseaseBAYLOR RES INST·Filed 2015·Granted Sep 5, 2017·48 cites·7 claims
- 0291US9066939B2Urinary triaosylceramide (GB3) as a marker of cardiac diseaseSCHIFFMANN RAPHAEL·Filed 2010·Granted Jun 30, 2015·49 cites·15 claims
- 0379US9468229B2Triheptanoin for the treatment of glucose transport 1 deficiencyNAT INST OF HEALTH AND MEDICAL RES·Filed 2013·Granted Oct 18, 2016·7 cites·29 claims
- 0466US8410101B2Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry diseaseSCHIFFMANN RAPHAEL·Filed 2010·Granted Apr 2, 2013·3 cites·5 claims
- 0549US10111848B2Triheptanoin for the treatment of glucose transport 1 deficiencyNATIONAL INSTITUTE OF HEALTH AND MEDICAL RES·Filed 2016·Granted Oct 30, 2018·0 cites·8 claims
- 0648US2019290610A1Triheptanoin for the treatment of glucose transport 1 deficiencyNATIONAL INSTITUTE OF HEALTH AND MEDICAL RES·Filed 2018·Application pending·0 cites
- 0745US2011112041A1Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry DiseaseBAYLOR RES INST·Filed 2010·Application pending·0 cites
- 0841US2011306663A1Triheptanoin diet for adult polyglucosan body disease (apbd) treatmentSCHIFFMANN RAPHAEL·Filed 2011·Application pending·0 cites
- 0924US2011217288A1Involvement of Androgen/Androgen Receptor Pathway in Fabry DiseaseBAYLOR RES INST·Filed 2011·Application pending·0 cites
- 1022US9155765B2Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs)MENG XINGLI·Filed 2012·Granted Oct 13, 2015·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Raphael Schiffmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →